CT Bhalla评分评估支气管扩张患者预后的价值

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (1089 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the estimated value of the prognosis of patients with bronchiectasis by CT Bhalla score. Methods A total of 80 patients with bronchiectasis admitted to Suqian People’s Hospital of Nanjing Drum-Tower Hospital Group from January 2016 to December 2018 were included. After admission, all patients received CT Bhalla score. Clinical data of the patients were collected, including gender, age, body mass index, risk grade, smoking history, duration of disease, number of acute exacerbations, Pseudomonas aeruginosa positiveness, percentage of forced expiratory volume in the first second to the predicted value (FEV1%pred), and the relationship between CT Bhalla score and clinical characteristics of the patients was analyzed. The patients were followed up for 12 months to analyze the prognosis, and were divided into good group (16 cases) and bad group (64 cases) according to the conditions of prognosis. CT Bhalla score was compared between the two groups, and receiver operating characteristic curve (ROC) was drawn to analyze the predictive value of CT Bhalla score in the prognosis of patients with bronchiectasis. Results CT Bhalla scores ranged from five to seventeen, with an average score of (9.27±1.26). There were statistically significant differences in CT Bhalla scores among patients with different ages, risk grade, duration of disease, number of acute exacerbations, Pseudomonas aeruginosa positiveness and FEV1%pred (all P ＜ 0.05). Among them, the CT Bhalla scores of high risk patients were significantly higher than those of medium risk patients and low risk patients, and medium risk patients were higher than those of low risk patients, and patients with acute exacerbations ≥three times per year were significantly higher than those with acute exacerbations two times per year and those with acute exacerbations one time per year. Patients with acute exacerbations two time sper year were significantly higher than those with acute exacerbations one time per year, with statistically significant differences (all P ＜ 0.05). CT Bhalla score in the bad group was significantly higher than those in the good group, and the difference was highly statistically significant (P ＜ 0.01). The AUC of CT Bhalla score for poor prognosis was 0.731 (standard error = 0.065, 95%CI = 0.603-0.859, P = 0.002), the best cutoff was 9.490 scofres, the sensitivity was 72.70%, and the specificity was 65.90%. Conclusion CT Bhalla score has a certain predictive value for the prognosis of patients with bronchiectasis.

Key words： Bronchiectasia CT Bhalla score Number of acute exacerbations Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHOU Jie1 WEN Ting2 GAO Wei2

Cite this article:

ZHOU Jie1 WEN Ting2 GAO Wei2. The value of CT Bhalla score in evaluating the prognosis of patients with bronchiectasis[J]. 中国医药导报, 2021, 18(5): 121-124,138.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2021/V18/I5/121

[1] Nikolic A. Pathophysiology and genetics of bronchiectasis unrelated to cystic fibrosis [J]. Lung，2018，196（4）：383-392.
[2] Battaglia S，Torres A，Polverino E. The importance of phenotyping bronchiectasis [J]. Respiration，2016，92（3）：134-135.
[3] 陈荣昌，关伟杰，钟南山.支气管扩张症：需要更多的关注和研究[J].中华结核和呼吸杂志，2017，40（1）：5-7.
[4] 赵明，王玉彩.支气管扩张患者营养风险与疾病严重程度相关性研究[J].实用临床医药杂志，2019，23（3）：60-62.
[5] 田志强，严天军.高分辨率CT扫描在提高诊断支气管扩张敏感性、准确性的应用价值[J].中国CT和MRI杂志，2016，14（4）：55-58.
[6] 任会丽，陈品儒，陈华，等.鸟-胞内分枝杆菌复合群与龟-脓肿分枝杆菌肺病并发支气管扩张的CT征象比较[J].中国防痨杂志，2019，41（2）：195-201.
[7] 成人支气管扩张症诊治专家共识编写组.成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志，2012，35（7）：485-492.
[8] 闻海梅，邓毅书.慢性阻塞性肺疾病合并支气管扩张的CT Bhalla评分与临床的相关性研究[J].临床肺科杂志，2016，21（12）：2216-2218.
[9] Henkle E，Aksamit TR，Barker AF，et al. Pharmacotherapy for non-cystic fibrosis bronchiectasis： results from an ntm info & research patient survey and the bronchiectasis and ntm research registry [J]. Chest，2017，152（6）：1120-1127.
[10] 胡旭，靳开宇，范贤明.慢性阻塞性肺疾病合并支气管扩张的发病机制、诊断与治疗研究进展[J].山东医药，2016，56（31）：106-108.
[11] 吴凤娟，亓倩，胡青，等.支气管扩张症患者肺部CT影像学特征与临床表现的相关性[J].中华医学杂志，2019， 99（38）：2982-2988.
[12] 张漫丽，张毅，李芳菲，等.支气管扩张合并感染的病原学及药物敏感性分析[J].实用药物与临床，2016，19（2）：240-243.
[13] 余跃丰，傅国良，张青春.灶周肺气肿与灶周支气管扩张对肺结核增殖结节CT诊断[J].医学影像学杂志，2019， 29（11）：1880-1883.
[14] 吴博云，杨卷红，于楠，等.支气管定量技术对支气管扩张的自动检测及形态分析[J].实用放射学杂志，2019， 35（8）：1332-1335.
[15] 刘向前，韩向前，孙晓霞，等.支气管扩张合并大咯血患者铜绿假单胞菌感染与影像学分析[J].中华医院感染学杂志，2019，29（11）：1665-1668.
[16] 陈华，陈品儒，谭守勇.支气管扩张并非结核分枝杆菌感染临床流行病学分析[J].中国医刊，2016，51（3）：43-46.
[17] 谢钊.支气管三维CT成像技术在小儿支气管扩张中的临床应用[J].中国医学物理学杂志，2017，34（12）：1246-1248.
[18] 颜密.儿童支气管扩张症病因的研究进展[J].国际儿科学杂志，2019，46（12）：896-900.
[19] 文曦琳，赖华，曹阳，等.低剂量容积高分辨率CT对儿童支气管扩张的诊断及临床价值[J].实用放射学杂志，2016，32（12）：1927-1929.
[10] 李杰，焦瑞，温林芳，等.支气管扩张症急性加重风险分层评分系统的构建及验证[J].中华结核和呼吸杂志，2016，39（8）：598-602.
[21] 程克斌，徐金富，李惠萍.支气管扩张症的免疫调节机制及其免疫调节治疗进展[J].国际呼吸杂志，2019，39（6）：457-461.
[22] 蔡仁萍，潘倩倩，时海洋，等.支气管扩张症合并慢性阻塞性肺病的早期诊治研究[J].中国医师进修杂志，2018， 41（11）：1025-1029.
[23] 吴玲，梁宗安.支气管扩张症-慢性阻塞性肺疾病重叠综合征临床特点分析[J].国际呼吸杂志，2020，40（2）：87-93.
[24] 孙智娜，何秀琴，拉毛卓玛，等.CT Bhalla评分与COPD合并支气管扩张患者肺功能、血气、炎症因子及气道阻力的关系[J].山东医药，2019，59（2）：52-54.
[25] 杨丽青，高凌云.支气管扩张症患者感染铜绿假单胞菌危险因素分析[J].国际呼吸杂志，2019，39（10）：758-761.